Milestone Pharmaceuticals Inc
MIST
Get informed when a big investor buys or sells
+ FollowMarket Cap$131.35M
Close$
$0.17
85.6% downside
Current Fair Value
85.6% downsideOvervalued by 85.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $131.35 Million |
|---|---|
| Enterprise Value | $22.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 0.98 |
| Outstanding Shares | 138,691,580 |
Return
| Return on Equity | -485.27% |
|---|---|
| Return on Assets | -48.68% |
| Return on Invested Capital | -42.06% |
Valuation & Multiples
| P/E Ratio | -1.53 |
|---|---|
| PEG | -1.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.17 |
| Enterprise Value to EBIT | -0.34 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.69 |
| Debt to Equity | 3.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$816,667
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$1.14 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 7.3085▲ 243.70% |
|---|---|
| Total Calls | 36,300▼ 79.19% |
| Total Puts | 265,300▼ 68.77% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 47.12%▼ 5.59% |
|---|---|
| Total Invested | $47.22M▼ 33.25% |
| Investors Holding | 91▲ 4.00% |
ESG Score
No data